These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 792359)

  • 21. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of results of clinical trials with amikacin.
    Gooding PG; Berman E; Lane AZ; Agre K
    J Infect Dis; 1976 Nov; 134 SUPPL():S441-5. PubMed ID: 792360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum concentrations and inhibitory ratios during amikacin therapy of gram-negative infections.
    Farchione LA; Chudzik GM
    J Clin Pharmacol; 1978; 18(8-9):432-8. PubMed ID: 690253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amikacin therapy for serious gram-negative bacillary infections.
    Meyer RD; Lewis RP; Carmalt ED; Finegold SM
    Ann Intern Med; 1975 Dec; 83(6):790-800. PubMed ID: 1200524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbenicillin for treatment of Bacteroides fragilis infections: why not penicillin G?
    Maki DG; Kurzynski TA; Agger WA
    J Infect Dis; 1978 Dec; 138(6):859-64. PubMed ID: 253006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and laboratory studies with amikacin in newborns, infants, and children.
    Trujillo H; Manotas R; Londono R; Ramirez JI; Uribe A; De Vidal EL; Agudelo N
    J Infect Dis; 1976 Nov; 134 SUPPL():S406-11. PubMed ID: 993632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous infusion tobramycin combined with carbenicillin for infections in cancer patients.
    Issell BF; Keating MJ; Valdivieso M; Bodey GP
    Am J Med Sci; 1979; 277(3):311-8. PubMed ID: 256433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with amikacin, a new aminoglycoside antibiotic.
    Theron FP; De Kock MA
    S Afr Med J; 1977 May; 51(21):746-8. PubMed ID: 327583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
    Yu VL; Rhame FS; Pesanti EL; Axline SG
    JAMA; 1977 Aug; 238(9):943-7. PubMed ID: 328950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled comparison of amikacin and gentamicin.
    Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
    N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination antibiotic therapy in pediatrics.
    Chadwick EG; Yogev R; Shulman ST
    Am J Med; 1986 Jun; 80(6B):166-71. PubMed ID: 3728528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
    Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
    Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
    Feld R; Valdivieso M; Bodey GP; Rodriguez V
    J Infect Dis; 1977 Jan; 135(1):61-6. PubMed ID: 401853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escherichia coli infections in knee joints. The pharmacological and antibacterial effects of intramuscular antibiotics.
    Schurman DJ; Kajiyama G; Nagel DA
    J Bone Joint Surg Am; 1980; 62(4):620-7. PubMed ID: 6991503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
    Chadwick EG; Shulman ST; Yogev R
    J Infect Dis; 1986 Oct; 154(4):670-5. PubMed ID: 3528320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.
    Winston DJ; Barnes RC; Ho WG; Young LS; Champlin RE; Gale RP
    Am J Med; 1984 Sep; 77(3):442-50. PubMed ID: 6475984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amikacin therapy for gram-negative septicemia.
    Meyer RD; Lewis RP; Finegold SM
    Am J Med; 1977 Jun; 62(6):930-5. PubMed ID: 868908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empiric antibiotic therapy with an amikacin-carbenicillin-cefoxitin combination in granulocytopenic febrile patients--a clinical report.
    Fernández-Rañada J; Fernández-Garese D; Caretti D; Vázquez L; Escudero A; Olmeda F
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):511-3. PubMed ID: 6642788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.